Dataset Information

Reconstructing cell cycle and disease progression using deep learning.

ABSTRACT: We show that deep convolutional neural networks combined with nonlinear dimension reduction enable reconstructing biological processes based on raw image data. We demonstrate this by reconstructing the cell cycle of Jurkat cells and disease progression in diabetic retinopathy. In further analysis of Jurkat cells, we detect and separate a subpopulation of dead cells in an unsupervised manner and, in classifying discrete cell cycle stages, we reach a sixfold reduction in error rate compared to a recent approach based on boosting on image features. In contrast to previous methods, deep learning based predictions are fast enough for on-the-fly analysis in an imaging flow cytometer.The interpretation of information-rich, high-throughput single-cell data is a challenge requiring sophisticated computational tools. Here the authors demonstrate a deep convolutional neural network that can classify cell cycle status on-the-fly.

SUBMITTER: Eulenberg P

PROVIDER: S-EPMC5587733 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Reconstructing cell cycle and disease progression using deep learning.

Eulenberg Philipp P Köhler Niklas N Blasi Thomas T Filby Andrew A Carpenter Anne E AE Rees Paul P Theis Fabian J FJ Wolf F Alexander FA

Nature communications 20170906 1

We show that deep convolutional neural networks combined with nonlinear dimension reduction enable reconstructing biological processes based on raw image data. We demonstrate this by reconstructing the cell cycle of Jurkat cells and disease progression in diabetic retinopathy. In further analysis of Jurkat cells, we detect and separate a subpopulation of dead cells in an unsupervised manner and, in classifying discrete cell cycle stages, we reach a sixfold reduction in error rate compared to a r ...[more]

PMID: 28878212

Similar Datasets

Project description:The highly rapid spread of the current pandemic has quickly overwhelmed hospitals all over the world and motivated extensive research to address a wide range of emerging problems. The unforeseen influx of COVID-19 patients to hospitals has made it inevitable to deploy a rapid and accurate triage system, monitor progression, and predict patients at higher risk of deterioration in order to make informed decisions regarding hospital resource management. Disease detection in radiographic scans, severity estimation, and progression and prognosis prediction have been extensively studied with the help of end-to-end methods based on deep learning. The majority of recent works have utilized a single scan to determine severity or predict progression of the disease. In this paper, we present a method based on deep sequence learning to predict improvement or deterioration in successive chest X-ray scans and build a mathematical model to determine individual patient disease progression profile using successive scans. A deep convolutional neural network pretrained on a diverse lung disease dataset was used as a feature extractor to generate the sequences. We devised three strategies for sequence modeling in order to obtain both fine-grained and coarse-grained features and construct sequences of different lengths. We also devised a strategy to quantify positive or negative change in successive scans, which was then combined with age-related risk factors to construct disease progression profile for COVID-19 patients. The age-related risk factors allowed us to model rapid deterioration and slower recovery in older patients. Experiments conducted on two large datasets showed that the proposed method could accurately predict disease progression. With the best feature extractor, the proposed method was able to achieve AUC of 0.98 with the features obtained from radiographs. Furthermore, the proposed patient profiling method accurately estimated the health profile of patients.

Project description:Early identification of individuals at risk of developing Alzheimer's disease (AD) dementia is important for developing disease-modifying therapies. In this study, given multimodal AD markers and clinical diagnosis of an individual from one or more timepoints, we seek to predict the clinical diagnosis, cognition and ventricular volume of the individual for every month (indefinitely) into the future. We proposed and applied a minimal recurrent neural network (minimalRNN) model to data from The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) challenge, comprising longitudinal data of 1677 participants (Marinescu et al., 2018) from the Alzheimer's Disease Neuroimaging Initiative (ADNI). We compared the performance of the minimalRNN model and four baseline algorithms up to 6 years into the future. Most previous work on predicting AD progression ignore the issue of missing data, which is a prevalent issue in longitudinal data. Here, we explored three different strategies to handle missing data. Two of the strategies treated the missing data as a "preprocessing" issue, by imputing the missing data using the previous timepoint ("forward filling") or linear interpolation ("linear filling). The third strategy utilized the minimalRNN model itself to fill in the missing data both during training and testing ("model filling"). Our analyses suggest that the minimalRNN with "model filling" compared favorably with baseline algorithms, including support vector machine/regression, linear state space (LSS) model, and long short-term memory (LSTM) model. Importantly, although the training procedure utilized longitudinal data, we found that the trained minimalRNN model exhibited similar performance, when using only 1 input timepoint or 4 input timepoints, suggesting that our approach might work well with just cross-sectional data. An earlier version of our approach was ranked 5th (out of 53 entries) in the TADPOLE challenge in 2019. The current approach is ranked 2nd out of 63 entries as of June 3rd, 2020.

Dataset Information

Reconstructing cell cycle and disease progression using deep learning.

Publications

Reconstructing cell cycle and disease progression using deep learning.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure